Prediagnostic plasma proteomics profile for hepatocellular carcinoma.

Xinyuan ZhangLonggang ZhaoLong H NgoSimon T DillonXuesong GuMichelle LaiTracey G SimonAndrew T ChanEdward L GiovannucciTowia A LibermannXuehong Zhang

Published in: Journal of the National Cancer Institute (2024)

However, the limited number of hepatocellular carcinoma patients in the cohorts necessitates caution in interpreting our findings, emphasizing the need for further validation in high-risk populations.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
mass spectrometry
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported
genetic diversity